Page last updated: 2024-11-11

isofraxidin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

isofraxidin: also see fraxidin [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5318565
CHEMBL ID451518
CHEBI ID81121
SCHEMBL ID3924718
MeSH IDM0051810

Synonyms (43)

Synonym
isofraxidin
nsc-324637
486-21-5
isofraxidin b814484k143
nsc324637
nsc 324637
brn 0202652
2h-1-benzopyran-2-one, 7-hydroxy-6,8-dimethoxy-
umbelliferone, 6,8-dimethoxy-
phytodolor
7-hydroxy-6,8-dimethoxy-2h-1-benzopyran-2-one
coumarin, 7-hydroxy-6,8-dimethoxy-
AKOS000278010
C17480
chebi:81121 ,
CHEMBL451518
7-hydroxy-6,8-dimethoxychromen-2-one
A827571
7-hydroxy-6,8-dimethoxy-chromen-2-one;isofraxidin
unii-304915f056
5-18-04-00332 (beilstein handbook reference)
304915f056 ,
S9240
FT-0688350
6,8-dimethoxyumbelliferone
7-hydroxy-6,8-dimethoxycoumarin
SCHEMBL3924718
7-hydroxy-6,8-dimethoxy-2h-chromen-2-one
Q-100542
HOEVRHHMDJKUMZ-UHFFFAOYSA-N
6,8-dimethoxy-7-hydroxycoumarin
FT-0698467
isofraxidin, analytical standard
DTXSID70197557
AC-8051
calycanthogenol
HY-N0774
mfcd00221757
isofraxidin ,(s)
Q15426264
CCG-266730
CS-0009797
BS-42209

Research Excerpts

Overview

Isofraxidin (IFD) is a natural coumarin isolated from the plants Sarcandra glabra and Siberian ginseng. It exerts anticancer, antioxidant and antiinflammatory effects.

ExcerptReferenceRelevance
"Isofraxidin is a coumarin compound mainly isolated from several traditional and functional edible plants beneficial for neurodegenerative diseases, including Sarcandra glabra and Apium graveolens, and Siberian Ginseng."( Protective effects of isofraxidin against scopolamine-induced cognitive and memory impairments in mice involve modulation of the BDNF-CREB-ERK signaling pathway.
Gu, J; Li, F; Lian, B; Wu, X; Yu, M; Zhang, C; Zhao, AZ; Zou, Z, 2022
)
2.48
"Isofraxidin (IF) is a coumarin compound widely found in plants, such as the Umbelliferae or Chloranthaceae families."( Isofraxidin enhances hyperthermia‑induced apoptosis via redox modification in acute monocytic leukemia U937 cells.
Ahmed, K; Cui, ZG; Jawaid, P; Kondo, T; Li, P; Noguchi, K; Rehman, MU; Saitoh, JI; Zhao, QL, 2023
)
3.07
"Isofraxidin is a well-known coumarin compound refined from traditional Chinese medicines. "( Isofraxidin Alleviates Myocardial Infarction Through NLRP3 Inflammasome Inhibition.
Chen, G; Lin, D; Song, X; Xu, P, 2020
)
3.44
"Isofraxidin (IFD) is a natural coumarin isolated from the plants Sarcandra glabra and Siberian ginseng, and exerts anticancer, antioxidant and antiinflammatory effects."( Isofraxidin ameliorated influenza viral inflammation in rodents via inhibiting platelet aggregation.
Jin, L; Wu, XN; Ying, ZH; Yu, CH; Yu, WY; Zhang, HH, 2020
)
2.72
"Isofraxidin is a hydroxy coumarin with several biological and pharmacological activities including an anti-osteoarthritis effect."( Isofraxidin Inhibits Receptor Activator of Nuclear Factor-κB Ligand-Induced Osteoclastogenesis in Bone Marrow-Derived Macrophages Isolated from Sprague-Dawley Rats by Regulating NF-κB/NFATc1 and Akt/NFATc1 Signaling Pathways.
Wang, B; Wang, W,
)
2.3
"Isofraxidin (IF) is a coumarin compound produced in the functional foods Siberian ginseng and Apium graveolens. "( Isofraxidin, a coumarin component improves high-fat diet induced hepatic lipid homeostasis disorder and macrophage inflammation in mice.
Ding, H; Li, J; Li, X; Li, Z; Liu, Y; Yin, S; Zhang, L, 2017
)
3.34
"Isofraxidin (IF) is a coumarin compound refined from traditional Chinese medicines with potential anti-inflammatory ability."( Isofraxidin inhibits interleukin-1β induced inflammatory response in human osteoarthritis chondrocytes.
Chen, K; Feng, Z; Li, X; Lin, J; Pan, X; Qi, W; Xu, X; Xue, X; Yan, Y, 2018
)
2.64
"Isofraxidin is a Coumarin compound widely distributed in plants, such as the Umbelliferae or Chloranthaceae, and it possesses numerous pharmacological activities. "( In vitro Inhibitory Effects of Isofraxidin on Human Liver Cytochrome P450 Enzymes.
Dong, G; Song, X; Zhou, Y, 2019
)
2.24
"Isofraxidin is a coumarin compound that possesses strong anti-inflammatory activity."( Isofraxidin attenuates IL-1β-induced inflammatory response in human nucleus pulposus cells.
Gao, Y; Gong, F; Liu, B; Lv, Z; Su, X; Sun, Q; Wang, X; Yin, J, 2019
)
2.68
"Isofraxidin (IF) is a Coumarin compound that can be isolated from medicinal plants, such as Sarcandra glabra (Thunb.). "( Isofraxidin exhibited anti-inflammatory effects in vivo and inhibited TNF-α production in LPS-induced mouse peritoneal macrophages in vitro via the MAPK pathway.
Fan, T; Hu, H; Li, W; Li, Y; Niu, X; Xing, W, 2012
)
3.26

Pharmacokinetics

ExcerptReferenceRelevance
"High-performance liquid chromatography coupled with solid phase extraction method was developed for determination of isofraxidin in rat plasma after oral administration of Acanthopanax senticosus extract (ASE), and pharmacokinetic parameters of isofraxidin either in ASE or pure compound were measured."( Pharmacokinetics of isofraxidin in rat plasma after oral administration of the extract of Acanthopanax senticosus using HPLC with solid phase extraction method.
Bi, K; Cao, H; Lv, H; Sun, H; Wang, X; Zhang, Y, 2007
)
0.87
"0 software was applied to calculate the pharmacokinetic parameters while the SPSS 17."( [Comparative pharmacokinetics of syringin, eleutheroside E and isofraxidin in rat plasma after intravenous administration of each monomer and Ciwujia injection].
Deng, ZP; Fan, HX; Xu, XT; Yao, QQ; Zhong, H, 2014
)
0.64

Dosage Studied

ASE has two maximum concentrations in plasma while the pure compound only showed one peak in the plasma concentration-time curve.

ExcerptRelevanceReference
" When the dosage of ASE is equal to pure compound caculated by the amount of isofraxidin, it has been found to have two maximum concentrations in plasma while the pure compound only showed one peak in the plasma concentration-time curve."( Pharmacokinetics of isofraxidin in rat plasma after oral administration of the extract of Acanthopanax senticosus using HPLC with solid phase extraction method.
Bi, K; Cao, H; Lv, H; Sun, H; Wang, X; Zhang, Y, 2007
)
0.89
"To establish a method for the determination of astilbin, peoniflorin, rasmarinci acid, isofraxidin and liquiritin contained in Shaolin Xiaoyin tablets, in order to lay a foundation for designing late-stage dosage forms and clinical medication schemes."( [Pharmacokinetic study on peoniflorin, astilbin, rosmarinic acid, isofraxidin and liquiritin in rat blood after oral administration of shaolin xiaoyin tablets].
Feng, LM; Lu, CJ; Wang, YJ; Zhao, RZ, 2014
)
0.86
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
hydroxycoumarinAny coumarin carrying at least one hydroxy substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID399085Cytotoxicity against human KB cells
AID1546529Cytotoxicity against human SKOV3 cells by SRB assay2020Bioorganic & medicinal chemistry, 01-01, Volume: 28, Issue:1
Artemisia: a promising plant for the treatment of cancer.
AID1546528Cytotoxicity against human SK-MEL-2 cells by SRB assay2020Bioorganic & medicinal chemistry, 01-01, Volume: 28, Issue:1
Artemisia: a promising plant for the treatment of cancer.
AID399086Cytotoxicity against mouse P388 cells
AID1546531Cytotoxicity against human HCT15 cells by SRB assay2020Bioorganic & medicinal chemistry, 01-01, Volume: 28, Issue:1
Artemisia: a promising plant for the treatment of cancer.
AID1546527Cytotoxicity against human A549 cells by SRB assay2020Bioorganic & medicinal chemistry, 01-01, Volume: 28, Issue:1
Artemisia: a promising plant for the treatment of cancer.
AID1332258Antineuroinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced NO production after 24 hrs in presence of LPS by Griess reaction based assay2017Bioorganic & medicinal chemistry letters, 01-15, Volume: 27, Issue:2
Biotransformation of isofraxetin-6-O-β-d-glucopyranoside by Angelica sinensis (Oliv.) Diels callus.
AID1546530Cytotoxicity against human XF498 cells by SRB assay2020Bioorganic & medicinal chemistry, 01-01, Volume: 28, Issue:1
Artemisia: a promising plant for the treatment of cancer.
AID1192870Antiinflammatory activity in mouse RAW264.7 cells assessed as decrease in LPS-induced NO production after 24 hrs by Griess assay2015Bioorganic & medicinal chemistry letters, Mar-01, Volume: 25, Issue:5
Constituents of the stem barks of Ailanthus altissima and their potential to inhibit LPS-induced nitric oxide production.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (54)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (1.85)18.7374
1990's3 (5.56)18.2507
2000's16 (29.63)29.6817
2010's26 (48.15)24.3611
2020's8 (14.81)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.10 (24.57)
Research Supply Index4.06 (2.92)
Research Growth Index5.37 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews5 (8.77%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other52 (91.23%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]